期刊文献+

促红细胞生成素对血管性痴呆大鼠胆碱能神经纤维保护作用的研究 被引量:3

Protective effect of erythropoietin on the expression of cholinergic neural fiber in the vascular dementia rat model
下载PDF
导出
摘要 目的:研究促红细胞生成素(Epo)对血管性痴呆(VD)大鼠胆碱能神经纤维的保护作用,探讨EPO对脑缺血后损伤的保护作用及其机制。方法:将大鼠随机分为假手术组、用药组和模型组,每组12只。用药组和模型组按"两血管阻断+硝普钠降压"法建立VD大鼠模型,并给予Epo治疗,采用Morris水迷宫实验、Nissl染色、乙酰胆碱酯酶(AchE)组化染色和AchE活性测定法检测Epo对学习记忆、细胞形态和AchE表达和活性的作用。结果:与假手术组和用药组相比,Epo明显缩短VD模型组大鼠Morris水迷宫中的逃避潜伏期,显著增加了海马CA1区锥体细胞及尼氏小体数量,并且显著提高了AchE免疫阳性细胞数量和AchE活性(P<0.01,P<0.05)。结论:EPO可改善VD大鼠行为学表现和病理损害,其机制可能与保护胆碱能神经纤维有关。 Objective: To study the protective effect of erythropoietin(Epo) on the expression of cholinergic neural fider in vascular dementia(VD) mt model. Methods: VD rat models were established by two-vessel occlusion and salium nitropnmside and they were treated by EPO. The Morris labyrinth, Nissl, acetylcholinesterase(AchE) histochemistric staining and AchE activity assessment methods were used to deteimine the influence of EPO on the study and memory, cellular morphous and AchE expression. Results: Compared with the sham-operative group and the Epo-treatment group, EPO significantly shortened the escaping latency of the Morris labyrinth and increased the number of neurons, Nissl bedies, AchE positive neurons fibers and AchE activity in the hippocampus and frontal cortex of the VD model group( P 〈 0.01 and P 〈0.05). Conclusion: Epo can improve the insults of praxiology and pathology of VD rats, which may be related to its protection of AchE neural fibers.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第8期813-816,共4页 Journal of Shandong University:Health Sciences
关键词 促红细胞生成素 痴呆 血管性 MORRIS水迷宫 乙酰胆碱酯酶 大鼠 Wistar Erythropoietin Dementia, vascular Morris water maze Acetylcholinesterase Rat, Wistar
  • 相关文献

参考文献13

  • 1Hasselblatt M,Ehrenreich H,Siren AL.The brain erythropoietin system and its potential for therapeutic exploitation in brain disease[J].J Neurosurg Anesthesiol,2006,18(2):132-138.
  • 2Grasso G.Erythropoietin:a new paradigm for neuroprotection[J].J Neurosurg Anesthesiol,2006,18(2):91-92.
  • 3Maiese K,Li F,Chong ZZ.Erythropoietin in the brain:can the promise to protect be fulfilled[J].Trends Pharmacol Sci,2004,25(11):577-583.
  • 4Hedreen JC,Bacon SJ,Price DL.A modified histochemical technique to visnalize acetylcholinesterase-containing axons[J].J Histochem Cytochem,1985,33(2):134-140.
  • 5Hirakata H,Yao H,Osato S,et al.CBF and oxygen metabolism in hemodialysis patients:effects of anemia correction with recombinant human EPO[J].Am J Physiol,1992,262(5 Pt 2):737-743.
  • 6Brines M,Ghezzi P,Keenan S,et al.Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury[J].Proc Natl Acad Sci,2000,97(19):10526-10531.
  • 7Erbayraktar S,Grasso G,Sfacteria A,et al.Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo[J].Proc Natl Acad Sci,2003,100(11):6741-6746.
  • 8Catania MA,Marciano MC,Parisi A,et al.Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils[J].Eur J Pharmacol,2002,437(3):147-150.
  • 9Celik M,Gokmen N,Erbayraktar S,et al.Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury[J].Proc Natl Acad Sci,2002,99(4):2258-2263.
  • 10Rinne JO,Kaasinen V,Jarvenpaa T,et al.Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease[J].J Neurol Neurosurg Psychiatry,2003,74(1):113-115.

同被引文献58

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部